Trials / Recruiting
RecruitingNCT07114653
The Role of POLE Mutation in High Risk Endometrial Cancer.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is: What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?
Detailed description
All high-risk recurrent endometrial cancer cases who were treated in a tertiary referral center will be analyzed and subjected to POLE mutation analysis. In addition, survival analysis will be used to analyze the role of POLE mutations in women with high-risk endometrial cancer. We can answers the following. 1. What is the prevalence of POLE mutations in women with high-risk endometrial cancer? 2. What is the role of POLE mutations in real world high-risk endometrial cancer?
Conditions
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-08-11
- Last updated
- 2025-08-11
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07114653. Inclusion in this directory is not an endorsement.